BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $2.799B (100.0% shares, 0.0% debt)

Holdings (44)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 33.3%

Value $932M Shares 19,751,284 Est. Cost — Unrealized —

KYMR KYMERA THERAPEUTICS INC 8.6%

Value $240M Shares 5,502,710 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES INC 6.5%

Value $183M Shares 4,982,384 Est. Cost — Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 6.3%

Value $177M Shares 3,211,041 Est. Cost — Unrealized —

AXSM AXSOME THERAPEUTICS INC 6.3%

Value $176M Shares 1,690,221 Est. Cost — Unrealized —

MIRM MIRUM PHARMACEUTICALS INC 5.0%

Value $141M Shares 2,761,333 Est. Cost — Unrealized —

GHRS GH RESEARCH PLC 3.8%

Value $108M Shares 8,827,712 Est. Cost — Unrealized —

IONS IONIS PHARMACEUTICALS INC 2.7%

Value $75.6M Shares 1,913,385 Est. Cost — Unrealized —

XOMA XOMA ROYALTY CORPORATION 2.3%

Value $65.28M Shares 2,590,303 Est. Cost — Unrealized —

ZYME ZYMEWORKS INC 1.9%

Value $54.08M Shares 4,308,935 Est. Cost — Unrealized —

SEPN SEPTERNA INC 1.7%

Value $46.47M Shares 4,396,124 Est. Cost — Unrealized —

CELC CELCUITY INC 1.7%

Value $46.27M Shares 3,466,000 Est. Cost — Unrealized —

KURA KURA ONCOLOGY INC 1.6%

Value $44.74M Shares 7,754,129 Est. Cost — Unrealized —

CGEM CULLINAN THERAPEUTICS INC 1.5%

Value $43.3M Shares 5,750,683 Est. Cost — Unrealized —

ACIU AC IMMUNE SA 1.4%

Value $40.24M Shares 19,822,436 Est. Cost — Unrealized —

— CIDARA THERAPEUTICS INC 1.4%

Value $38.31M Shares 786,392 Est. Cost — Unrealized —

TYRA TYRA BIOSCIENCES INC 1.3%

Value $37.75M Shares 3,944,194 Est. Cost — Unrealized —

GPCR STRUCTURE THERAPEUTICS INC 1.3%

Value $36.74M Shares 1,771,417 Est. Cost — Unrealized —

IMCR IMMUNOCORE HLDGS PLC 1.1%

Value $32.14M Shares 1,024,288 Est. Cost — Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 0.9%

Value $25.53M Shares 5,660,132 Est. Cost — Unrealized —

FHTX FOGHORN THERAPEUTICS INC 0.9%

Value $24.92M Shares 5,302,000 Est. Cost — Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 0.8%

Value $22.56M Shares 5,295,893 Est. Cost — Unrealized —

CBIO CRESCENT BIOPHARMA INC. 0.8%

Value $22.4M Shares 1,387,863 Est. Cost — Unrealized —

XNCR XENCOR INC 0.8%

Value $21.54M Shares 2,740,141 Est. Cost — Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 0.6%

Value $17.17M Shares 4,629,289 Est. Cost — Unrealized —

ELDN ELEDON PHARMACEUTICALS INC 0.6%

Value $17.05M Shares 6,293,282 Est. Cost — Unrealized —

ANNX ANNEXON INC 0.6%

Value $16.8M Shares 7,000,000 Est. Cost — Unrealized —

PVLA PALVELLA THERAPEUTICS INC NE 0.6%

Value $15.7M Shares 696,555 Est. Cost — Unrealized —

— ESSA PHARMA INC 0.5%

Value $14.87M Shares 8,748,629 Est. Cost — Unrealized —

— REPARE THERAPEUTICS INC 0.5%

Value $14.36M Shares 10,333,600 Est. Cost — Unrealized —

VSTM VERASTEM INC 0.5%

Value $14.13M Shares 3,404,425 Est. Cost — Unrealized —

RAPT RAPT THERAPEUTICS INC 0.3%

Value $9.238M Shares 1,154,692 Est. Cost — Unrealized —

FBRX FORTE BIOSCIENCES INC 0.3%

Value $7.607M Shares 588,344 Est. Cost — Unrealized —

TCRX TSCAN THERAPEUTICS INC 0.3%

Value $7.578M Shares 5,226,074 Est. Cost — Unrealized —

— IKENA ONCOLOGY INC 0.2%

Value $5.369M Shares 4,006,564 Est. Cost — Unrealized —

IMUX IMMUNIC INC 0.2%

Value $5.338M Shares 7,652,972 Est. Cost — Unrealized —

MOLN MOLECULAR PARTNERS AG 0.2%

Value $5.186M Shares 1,353,968 Est. Cost — Unrealized —

AVTX AVALO THERAPEUTICS INC 0.2%

Value $5.13M Shares 1,028,049 Est. Cost — Unrealized —

IVA INVENTIVA SA 0.1%

Value $2.14M Shares 686,040 Est. Cost — Unrealized —

TENX TENAX THERAPEUTICS INC 0.1%

Value $1.983M Shares 339,549 Est. Cost — Unrealized —

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value $1.606M Shares 917,826 Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 0.0%

Value $1.271M Shares 3,853,818 Est. Cost — Unrealized —

ENGNW ENGENE HOLDINGS INC 0.0%

Value $586K Shares 945,402 Est. Cost — Unrealized —

— NLS PHARMACEUTICS LTD 0.0%

Value $417K Shares 143,676 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	19,751,284	$932M	33.3%	—	—	CLASS A ORD	61559X104
KYMR	KYMERA THERAPEUTICS INC	5,502,710	$240M	8.6%	—	—	COM	501575104
RVMD	REVOLUTION MEDICINES INC	4,982,384	$183M	6.5%	—	—	COM	76155X100
PTGX	PROTAGONIST THERAPEUTICS INC	3,211,041	$177M	6.3%	—	—	COM	74366E102
AXSM	AXSOME THERAPEUTICS INC	1,690,221	$176M	6.3%	—	—	COM	05464T104
MIRM	MIRUM PHARMACEUTICALS INC	2,761,333	$141M	5.0%	—	—	COM	604749101
GHRS	GH RESEARCH PLC	8,827,712	$108M	3.8%	—	—	ORDINARY SHARES	G3855L106
IONS	IONIS PHARMACEUTICALS INC	1,913,385	$75.6M	2.7%	—	—	COM	462222100
XOMA	XOMA ROYALTY CORPORATION	2,590,303	$65.28M	2.3%	—	—	COM NEW	98419J206
ZYME	ZYMEWORKS INC	4,308,935	$54.08M	1.9%	—	—	COM	98985Y108
SEPN	SEPTERNA INC	4,396,124	$46.47M	1.7%	—	—	COM	81734D104
CELC	CELCUITY INC	3,466,000	$46.27M	1.7%	—	—	COM	15102K100
KURA	KURA ONCOLOGY INC	7,754,129	$44.74M	1.6%	—	—	COM	50127T109
CGEM	CULLINAN THERAPEUTICS INC	5,750,683	$43.3M	1.5%	—	—	COM	230031106
ACIU	AC IMMUNE SA	19,822,436	$40.24M	1.4%	—	—	SHS	H00263105
—	CIDARA THERAPEUTICS INC	786,392	$38.31M	1.4%	—	—	COM NEW	171757206
TYRA	TYRA BIOSCIENCES INC	3,944,194	$37.75M	1.3%	—	—	COM	90240B106
GPCR	STRUCTURE THERAPEUTICS INC	1,771,417	$36.74M	1.3%	—	—	SPONSORED ADS	86366E106
IMCR	IMMUNOCORE HLDGS PLC	1,024,288	$32.14M	1.1%	—	—	ADS	45258D105
GLUE	MONTE ROSA THERAPEUTICS INC	5,660,132	$25.53M	0.9%	—	—	COM	61225M102
FHTX	FOGHORN THERAPEUTICS INC	5,302,000	$24.92M	0.9%	—	—	COM	344174107
OLMA	OLEMA PHARMACEUTICALS INC	5,295,893	$22.56M	0.8%	—	—	COM	68062P106
CBIO	CRESCENT BIOPHARMA INC.	1,387,863	$22.4M	0.8%	—	—	COM	G2545C104
XNCR	XENCOR INC	2,740,141	$21.54M	0.8%	—	—	COM	98401F105
FDMT	4D MOLECULAR THERAPEUTICS IN	4,629,289	$17.17M	0.6%	—	—	COM	35104E100
ELDN	ELEDON PHARMACEUTICALS INC	6,293,282	$17.05M	0.6%	—	—	COM	28617K101
ANNX	ANNEXON INC	7,000,000	$16.8M	0.6%	—	—	COM	03589W102
PVLA	PALVELLA THERAPEUTICS INC NE	696,555	$15.7M	0.6%	—	—	COM	697947109
—	ESSA PHARMA INC	8,748,629	$14.87M	0.5%	—	—	COM NEW	29668H708
—	REPARE THERAPEUTICS INC	10,333,600	$14.36M	0.5%	—	—	COM	760273102
VSTM	VERASTEM INC	3,404,425	$14.13M	0.5%	—	—	COM NEW	92337C203
RAPT	RAPT THERAPEUTICS INC	1,154,692	$9.238M	0.3%	—	—	COM NEW	75382E208
FBRX	FORTE BIOSCIENCES INC	588,344	$7.607M	0.3%	—	—	COM NEW	34962G208
TCRX	TSCAN THERAPEUTICS INC	5,226,074	$7.578M	0.3%	—	—	COM	89854M101
—	IKENA ONCOLOGY INC	4,006,564	$5.369M	0.2%	—	—	COM	45175G108
IMUX	IMMUNIC INC	7,652,972	$5.338M	0.2%	—	—	COM	4525EP101
MOLN	MOLECULAR PARTNERS AG	1,353,968	$5.186M	0.2%	—	—	ADS	60853G106
AVTX	AVALO THERAPEUTICS INC	1,028,049	$5.13M	0.2%	—	—	COM NEW	05338F306
IVA	INVENTIVA SA	686,040	$2.14M	0.1%	—	—	ADS	46124U107
TENX	TENAX THERAPEUTICS INC	339,549	$1.983M	0.1%	—	—	COM NEW	88032L605
SABS	SAB BIOTHERAPEUTICS INC	917,826	$1.606M	0.1%	—	—	COM NEW	78397T202
OVID	OVID THERAPEUTICS INC	3,853,818	$1.271M	0.0%	—	—	COM	690469101
ENGNW	ENGENE HOLDINGS INC	945,402	$586K	0.0%	—	—	*W EXP 10/31/202	29286M113
—	NLS PHARMACEUTICS LTD	143,676	$417K	0.0%	—	—	COM NEW	H57830137